Myoepithelioma: Clinical Trials

5 trials for Myoepithelioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 2 unknown, 1 completed. 4 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Recruiting 2, Unknown 2
Phase 23Recruiting 2, Unknown 1

Follow Myoepithelioma: new trials by email Literature Review of Myoepithelioma trials Research Report on Myoepithelioma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Miltenyi CliniMACS Prodigy ® system, Zoledronic acid - Neuroblastoma, Rhabdomyosarcoma
Phase 1 / Phase 2RecruitingUniversity of Florida272026-02-112026-06-30
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Surgical resection, Proton beam radiation therapy, Pazopanib - Adipocytic Neoplasm, Liposarcoma
Phase 1 / Phase 2RecruitingSt. Jude Children's Research Hospital1392024-03-272026-08-03
Malignant Myoepithelioma of Bone and Soft Tissues: Diagnostic Imaging and Histology in Relation to Prognosis
Clinical data review - Myoepithelioma
CompletedIstituto Ortopedico Rizzoli332024-01-102025-04-01
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)
Seclidemstat - Ewing Sarcoma, Myxoid Liposarcoma
Phase 1 / Phase 2UnknownSalarius Pharmaceuticals, LLC102022-01-152023-08-01
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
Seclidemstat, Cyclophosphamide, Topotecan - Ewing Sarcoma, Myxoid Liposarcoma
Phase 1UnknownSalarius Pharmaceuticals, LLC502018-06-042023-11-21

Narrower conditions

Sarcoma, Clear Cell (4)  ·  Chondrosarcoma, Extraskeletal Myxoid (3)  ·  Desmoplastic Small Round Cell Tumor (3)  ·  Histiocytoma, Angiomatoid Fibrous (3)  ·  Liposarcoma, Myxoid (3)  ·  Sarcoma (3)  ·  Sarcoma, Ewing (3)  ·  Nerve Sheath Neoplasms (2)  ·  Osteosarcoma (2)  ·  Sarcoma, Synovial (2)  ·  Chordoma (1)  ·  Dermatofibrosarcoma (1)  ·  Disorders of Sex Development (1)  ·  Fibroma (1)

Broader conditions

Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms, Complex and Mixed (5)  ·  Neoplasms, Bone Tissue (4)  ·  Neoplasms, Connective Tissue (4)  ·  Neoplasms, Connective and Soft Tissue (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Liposarcoma (2)  ·  Male Urogenital Diseases (2)  ·  Neoplasms, Adipose Tissue (2)  ·  Neoplasms, Fibrous Tissue (2)  ·  Neoplasms, Muscle Tissue (2)  ·  Neoplasms, Nerve Tissue (2)

Interventions

Cyclophosphamide (2)  ·  Topotecan (2)  ·  seclidemstat (2)  ·  Doxorubicin (1)  ·  Ifosfamide (1)  ·  Proton Therapy (1)  ·  Zoledronic Acid (1)  ·  pazopanib (1)  ·  selinexor (1)

Sponsors

Salarius Pharmaceuticals, LLC (2)  ·  Istituto Ortopedico Rizzoli (1)  ·  St. Jude Children's Research Hospital (1)  ·  University of Florida (1)

Countries

United States (4)  ·  Italy (1)

Top investigators

Jessica Gartrell, MD (1)  ·  Jordan Milner, MD (1)

Results publications

PMID 25299310, PMID 33526224